Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
KYORIN Pharmaceutical Co Ltd (4569) - Financial and Strategic SWOT Analysis Review
KYORIN Pharmaceutical Co Ltd (4569) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More
-
Towa Pharmaceutical Co Ltd (4553) - Financial and Strategic SWOT Analysis Review
Towa Pharmaceutical Co Ltd (4553) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review
Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t ... Read More
-
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre ... Read More
-
Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review
Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Jubilant Pharmova Ltd (JUBLPHARMA) - Financial and Strategic SWOT Analysis Review
Jubilant Pharmova Ltd (JUBLPHARMA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review
Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths ... Read More
-
Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review
Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak ... Read More
-
Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review
Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review
Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn ... Read More
-
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Regi ... Read More
-
Orthopedic Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Orthopedic Prosthetics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Orthopedic Prosthetics Pipeline Report including Stages of Development, Segments, Region and Cou ... Read More
-
Celiac Disease: Competitive Landscape
Celiac Disease: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Celiac Disease therapeutics. In 2024, more than 3.7 million diagnosed prevalent cases of CD are anticipated in the 16 countries covered in GlobalData’s epidem ... Read More
-
UK Sector Series: Health & Beauty, 2023-2028
UK Sector Series: Health & Beauty, 2023-2028 Summary The UK Health & Beauty report offers a comprehensive insight into the Health & Beauty market in the UK, analysing the sector, the major players, the main trends, and consumer attitudes, as well as providing market forecasts out to 2028. The UK hea ... Read More
-
Focal Segmental Glomerulosclerosis: Competitive Landscape
Focal Segmental Glomerulosclerosis: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics. In 2024, more than 36,000 diagnosed incident cases of FSGS are anticipated in the 16 coun ... Read More
-
Acute coronary syndrome: Competitive Landscape
Acute coronary syndrome: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute coronary syndrome therapeutics. In 2024, more than 7.8 million hospitalized incident cases of ACS are anticipated in the 16 countries covered i ... Read More
-
Epstein-Barr Virus: Competitive Landscape
Epstein-Barr Virus: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Epstein-Barr Virus therapeutics. In 2024, more than 700 million people are at risk of EBV infection in the 16 countries covered in GlobalData’s epidemiolo ... Read More
-
Saudi Pharmaceutical Industries & Medical Appliances Corp (2070) - Financial and Strategic SWOT Analysis Review
Saudi Pharmaceutical Industries & Medical Appliances Corp (2070) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of t ... Read More
-
Hisamitsu Pharmaceutical Co Inc (4530) - Financial and Strategic SWOT Analysis Review
Hisamitsu Pharmaceutical Co Inc (4530) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths ... Read More
-
Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review
Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes ... Read More
-
Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review
Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More
-
Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review
Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes ... Read More
-
Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review
Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt ... Read More
-
Opportunities in the Asia-Pacific Consumer Health Industry 2024
Opportunities in the Asia-Pacific Consumer Health Industry 2024 Summary This report brings together multiple data sources to provide a comprehensive overview of the Asia-Pacific consumer health industry, analyzing data from 26 countries in the region. It includes an analysis of the following: Market ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
Migraine: 68-Market Analysis and Sales Forecast Summary GlobalData estimates that the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventative treatments including widely used triptans and ergot alkaloids used in abortive treatment a ... Read More
Research Assistance
